CLINICAL TRIALS PROFILE FOR SEIZALAM
✉ Email this page to a colleague
All Clinical Trials for SEIZALAM
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT04679623 ↗ | Study of Midazolam in Healthy Adults | Not yet recruiting | Joint Project Management Office for Chemical, Biological, Radiological, and Nuclear Medical | Phase 1 | 2021-05-03 | This study is a phase 1, open-label, crossover, comparison study to evaluate the safety and pharmacokinetics (PK) of a single IM administration of 10 mg midazolam using Rafa's auto-injector compared with seizalam in healthy adults. All subjects will participate in both study periods which will span 28 days following a pre study screening visit. |
NCT04679623 ↗ | Study of Midazolam in Healthy Adults | Not yet recruiting | Ology Bioservices | Phase 1 | 2021-05-03 | This study is a phase 1, open-label, crossover, comparison study to evaluate the safety and pharmacokinetics (PK) of a single IM administration of 10 mg midazolam using Rafa's auto-injector compared with seizalam in healthy adults. All subjects will participate in both study periods which will span 28 days following a pre study screening visit. |
NCT04679623 ↗ | Study of Midazolam in Healthy Adults | Not yet recruiting | Rafa Laboratories | Phase 1 | 2021-05-03 | This study is a phase 1, open-label, crossover, comparison study to evaluate the safety and pharmacokinetics (PK) of a single IM administration of 10 mg midazolam using Rafa's auto-injector compared with seizalam in healthy adults. All subjects will participate in both study periods which will span 28 days following a pre study screening visit. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for SEIZALAM
Condition Name
Clinical Trial Progress for SEIZALAM
Clinical Trial Phase
Clinical Trial Sponsors for SEIZALAM
Sponsor Name